Natco Pharma Challenges Novo Nordisk’s Wegovy Patent, Reaches Delhi High Court We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novo Nordisk has been handed a crucial legal win by China’s Supreme Court, which has upheld the company’s patent protection on GLP-1 agonist semaglutide used for diabetes and weight loss. The court in Beijing backed the validity of Novo Nordisk’s compound patent for semaglutide, which is the main ingredient in the company’s obesity therapy Wegovy…
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy’s to Continue We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Delhi HC Rejects FMC Plea, Clears Natco to Launch Cyantraniliprole Ahead of Patent Expiry We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis Loses India Patent on Heart Failure Drug Vymada We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link